Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB08935"
| Predicate | Value (sorted: none) |
|---|---|
| drugbank:description |
"Obinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. It was approved by the FDA in November 2013 and is marketed under the brand name Gazyva. There is a black box warning of fatal Hepatitis B Virus (HBV) reactivation and fatal Progressive Multifocal Leukoencephalopathy (PML)."
|
| rdf:type | |
| drugbank:drugCategory | |
| rdfs:label |
"Obinutuzumab"
|
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource does not appear as an object